Please ensure Javascript is enabled for purposes of website accessibility
ホーム > 製品 > 抗体 > 中和抗体

InVivoMAb Anti-Mouse TRANCE/TNFSF11/RANK L Antibody (7C6) (MT439010)

InVivoMAb Anti-Mouse TRANCE/TNFSF11/RANK L Antibody (7C6)
InVivoMAb Anti-Mouse TRANCE/TNFSF11/RANK L Antibody (7C6)
価格(USD):
スペック:
  • 100ug
  • 1mg
数量:
お問い合わせ
  • 概要

  • イメージ

  • 参考文献

  • データシート

  • SDS

概要
カタログ番号MT439010
説明
InVivoMAb Anti-Mouse CD254/RANKL Antibody (7C6) [7C6] (MT439010) is a mouse monoclonal antibody detecting Tumor necrosis factor ligand superfamily member 11 in ELISA, Neutralization. Suitable for Mouse.
種反応性Mouse
アプリケーションELISA, Neutralization
宿主種Mouse
クローン性Monoclonal
アイソタイプVHH-mFc
クローンID7C6
ターゲット Tumor necrosis factor ligand superfamily member 11, Osteoclast differentiation factor, ODF, Osteoprotegerin ligand, OPGL, Receptor activator of nuclear factor kappa-B ligand, RANKL, TNF-related activation-induced cytokine, TRANCE, CD254, Tumor necrosis factor ligand superfamily member 11, membrane form, Tumor necrosis factor ligand superfamily member 11, soluble form, Tnfsf11, Opgl, Rankl, Trance
エンドトキシンレベル Please contact with the lab for this information.
純度 >95% as determined by SDS-PAGE.
関連製品 pH 7.4 Dilution Buffer
精製 Protein A/G purified from cell culture supernatant.
アクセッション番号 O35235
形態 Liquid
保存バッファー 0.01M PBS pH 7.4

データシートのハードコピーまたはロット固有のCOAに記載された具体的なバッファー情報を参照してください。

安定性と保存 Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.
背景

Tumor necrosis factor ligand superfamily member 11 (CD254/RANKL) is a ~35 kDa protein. Cytokine that binds to TNFRSF11B/OPG and to TNFRSF11A/RANK. Osteoclast differentiation and activation factor. Augments the ability of dendritic cells to stimulate naive T-cell proliferation. May be an important regulator of interactions between T-cells and dendritic cells and may play a role in the regulation of the T-cell-dependent immune response. May also play an important role in enhanced bone-resorption in humoral hypercalcemia of malignancy. CD254 is the therapeutic target of denosumab (Prolia).

1. Linares, GR. et al. (2012) Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 27, 1553-65. PMID: 22437732
2. Mahoney, DJ. et al. (2008) The Journal of biological chemistry 283, 25952-62. PMID: 18586671
3. Tiedemann, K. et al. (2013) Journal of cell science 126, 4187-94. PMID: 24039232
4. Omata, Y. et al. (2016) PloS one 11, e0157992. PMID: 27336669
5. Kim, H. et al. (2013) Cell metabolism 17, 249-60. PMID: 23395171
6. Decker, CE. et al. (2015) Proceedings of the National Academy of Sciences of the United States of America 112, 15654-9. PMID: 26644563
注意事項 For research use only. Not suitable for clinical or therapeutic use.
Isotype Control VHH mIgG2a Fc Recombinant Isotype Control Antibody (HyHEL-10) (MP167023)
イメージ
  • InVivoMAb Anti-Mouse TRANCE/TNFSF11/RANK L Antibody (7C6)

    SDS-PAGE

    SDS-PAGE for InVivoMAb Anti-Mouse CD254/RANKL Antibody (7C6).

参考文献
Formula
Mass (g) = Concentration (mol/L) × Volume (L) × MW (g/mol)
Enter any 2 of Mass, Concentration, Volume + Molecular Weight to solve for the unknown.
Mass
=
Concentration
×
Volume
Molecular Weight *
g/mol
Formula
C₁ × V₁ = C₂ × V₂
Enter any 3 of the 4 values to solve for the unknown.
Stock Solution
C₁ (Stock Conc.)
×
V₁ (Stock Vol.)
=
Working Solution
C₂ (Working Conc.)
×
V₂ (Working Vol.)
レコメンデーション

お問い合わせ カスタムクォート、大量リクエストおよびその他の問題については

メール: [email protected]

ディストリビューターリスト